Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H
Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Norma Fantini(University of Milan), Vittorio Ruggero Zilioli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Maria Cristina Pasquini(Azienda Ospedaliera Ospedale Maggiore), M Viganò(University of Basel), Monica Colombo(Ospedale Policlinico San Martino)
Cited by 39
Related Papers
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394